Single CRISPR infusion cuts stubborn LDL cholesterol for a year
A single dose of CTX310, a CRISPR-Cas9 therapy, dropped LDL cholesterol by more than half in patients who did not respond to standard drugs. The effect lasted at least a year.
A single dose of CTX310, a CRISPR-Cas9 therapy, dropped LDL cholesterol by more than half in patients who did not respond to standard drugs. The effect lasted at least a year.
MDU's Centre for Biotechnology brought leading scientists to campus to dissect how gene editing tools like CRISPR-Cas9 are reshaping malaria research and student training.
Researchers at ICAR-Central Rice Research Institute have shown that Plant OpenCRISPR-1, an AI-designed genome editor, works as well as established systems for editing rice genes.
A coalition of scientists and farmers is urging the Indian government to stop gene edited rice, warning of health, environmental, and economic risks, and calling for a return to Dr Richharia’s sustainable approach to agriculture.
Florida citrus growers are betting on gene edited rootstock to fight a bacterial disease that has decimated their groves and production.